0%
Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Survey of Challenges in Access to Diagnostics and Treatment for Neuroendocrine Tumor Patients (SCAN) 

You are invited to participate in SCAN - a global survey on neuroendocrine tumor (NET) patients' experience in navigating their healthcare system. This survey is conducted by the International Neuroendocrine Cancer Alliance (INCA) to raise awareness of patient access to diagnostics and treatment, and to help improve such access.

This survey is strictly anonymous. It doesn't collect any personal data that could relate the responses provided to yourself.

If you are a NET patient, a family member, partner or friend caring for a NET patient or a caregiver paid to provide services to a NET patient, please share your experience.

It should only take about 20 minutes of your time.

Before you begin this survey, there are a few questions to determine if you qualify.

Thank you for your help!

Privacy policy: INCA
Privacy policy Limesurvey
(This question is mandatory)
S1. Are you a: